Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex

Journal of Neurochemistry

Volumn 96, Issue 2, 2006, Pages 473-481

  Carboni, Ezio ^a   Silvagni, Alessandra ^a   Vacca, Cinzia ^a   Di Chiara, Gaetano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Catecholamine transporters; Dopamine; GBR 12909; Noradrenaline; Nucleus accumbens; Reboxetine

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; NORADRENALIN; PSYCHOSTIMULANT AGENT; REBOXETINE; VANOXERINE; DOPAMINE UPTAKE INHIBITOR; MORPHOLINE DERIVATIVE; NORADRENALIN TRANSPORTER; PIPERAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CATECHOLAMINE UPTAKE; CAUDATE NUCLEUS; CONTROLLED STUDY; DIALYSATE; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; DRUG MECHANISM; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRIA TERMINALIS; ANIMAL; DRUG ANTAGONISM; EXTRACELLULAR FLUID; METABOLISM; SEPTUM NUCLEUS; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALIA;

ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR FLUID; MALE; MORPHOLINES; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; NUCLEUS ACCUMBENS; PIPERAZINES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI; TISSUE DISTRIBUTION;

EID: 33644878101     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03556.x     Document Type: Article

References (63)

1. Andersen PH. 1989 The dopamine uptake inhibitor GBR 12909 EurJPharmacol 32 493 504
2. Arnsten AF. 2004 Adrenergic targets for the treatment of cognitive deficits in schizophrenia Psychopharmacology (Berl) 174 25 31
3. Baumann MH. Phillips JM. Ayestas MA. Ali SF. Rice KC. Rothman RB. 2002 Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence AnnNY AcadSci 965 92 108
4. Berridge CW. Stratford TL. Foote SL. Kelley AE. 1997 Distribution of dopamine β-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens Synapse 27 230 241
5. Budygin EA. John CE. Mateo Y. Jones SR. 2002 Lack of cocaine effect on dopamine transporter clearance in the core and shell of the nucleus accumbens of dopamine e transporter knock-out mice JNeurosci 20 RC 222 1 4 q20
6. Budygin EA. Brodie MS. Sotnikova TD. Mateo Y. John CE. Cyr M. Gainetdinov RR. Jones SR. 2004 Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine ProcNatl AcadSciUSA 101 7781 7786
7. Bymaster FP. Katner JS. Nelson DL. Hemrick-Luecke SK. Threlkeld PG. Heiligenstein JH. Morin SM. Gehlert DR. Perry KW. 2002 Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 699 711
8. Carboni E. Imperato A. Perezzani L. Di Chiara G. 1989 Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats Neuroscience 28 653 661
9. Carboni E. Tanda G. Frau R. Di Chiara G. 1990 Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals JNeurochem 55 1067 1090
10. Carboni E. Silvagni A. Rolando MPT. Di Chiara G. 2000 Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs JNeurosci 20 RC 102 1 5 q21
11. Carboni E. Spielewoy C. Vacca C. Nosten-Bertrand M. Giros B. Di Chiara G. 2001 Cocaine and Amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene JNeurosci 21 RC 141 1 4 q22
12. Chalon S. Garreau L. Emond P. Zimmer L. Vilar MP. Besnard JC. Guilloteau D. 1999 Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β- carbomethoxy-3β-(4′-methylphenyl) nortropane as a selective and potent inhibitor of the neuronal dopamine transporter JPharmacolExpTher 291 648 654
13. Ciliax BJ. Heilman C. Demchyshyn LL. Pristupa ZB. Ince E. Hersh SM. Niznik HB. Levey AI. 1995 The dopamine transporter: immunolocalization characterization and localization in brain JNeurosci 15 1714 1723
14. Davidson RJ. Pizzagalli D. Nitschke JB. Putnam K. 2002 Depression: perspectives from affective neuroscience AnnRevPsychol 53 545 574
15. Delfs JM. Zhu Y. Druhan JP. Aston-Jones GS. 1998 Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat Brain Res 806 127 140
16. Deutch AY. Cameron DS. 1992 Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell Neuroscience 46 49 56
17. Deutch AY. Goldstein M. Baldino F. Jr. Roth RH. 1988 Telencephalic projections of the A8 dopamine cell group AnnNY AcadSci 537 27 50
18. Devoto P. Flore G. Pani L. Gessa GL. 2001 Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex MolPsychiatry 6 657 664
19. Devoto P. Flore G. Longu G. Pira L. Gessa GL. 2003 Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex Synapse 50 200 205
20. Di Chiara G. 1995 The role of dopamine in drug abuse viewed from the perspective of its role in motivation Drug Alcohol Depend 38 95 137
21. Di Chiara G. Tanda G. Frau R. Carboni E. 1992 Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers NeurochemInt 20 231s 235s
22. Di Chiara G. Tanda G. Frau R. Carboni E. 1993 On the preferentially release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes Psychoparmacology 112 398 402
23. Garris PA. Ciolkowski EL. Pastore P. Wightman RM. 1994 Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain JNeurosci 14 6084 6093
24. Giros B. Jaber M. Jones SR. Wightman RM. Caron MG. 1996 Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 606 612
25. Gobert A. Rivet JM. Cistarelli L. Melon C. Millan MJ. 1999 Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of α2-adrenergic receptors underlie its actions Neuroscience 93 1251 1262
26. Hajos M. Fleishaker JC. Filipiak-Reisner JK. Brown MT. Wong EH. 2004 The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile CNS Drug Rev 10 23 44
27. 3H-norepinephrine in slices of rat neostriatum and cerebral cortex JPharmacolExpTher 194 47 56
28. Heimer L. Alheid GF. Zahm DS. 1993 Basal forebrain organization: an anatomical framework for motor aspects of drive and motivation, in Limbic Motor Circuits and Neuropsychiatry Kalivas PW. Barnes CD., eds) CRC Press Boca Raton FL
29. Howell LL. Byrd LD. 1991 Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behaviour in the squirrel monkey JPharmacolExpTher 258 178 185
30. Jones RS. Gainetdinov RR. Wightman RM. Caron MG. 1998 Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter JNeurosci 18 1979 1986
31. Koob GF. 1992 Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Neurosci 13 177 184
32. Kuczenski R. Segal DS. Aizenstein ML. 1991 Amphetamine, cocaine and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics JNeurosci 11 2703 2712
33. Letchworth SR. Smith HR. Porrino LJ. Bennett BA. Davies HM. Sexton T. Childers SR. 2000 Characterization of a tropane radioligand, [(3)H]2β-propanoyl-3β-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain JPharmacolExpTher 293 686 696
34. Liang NY. Rutledge CO. 1982 Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine BiochemPharmacol 31 983 992
35. Mack F. Bonisch H. 1979 Dissociation constants and lipophilicity of catecholamines and related compounds Naunyn Schmiedebergs ArchPharmacol 310 1 9
36. Miles PR. Mundorf ML. Wightman RM. 2002 Release and uptake of catecholamines in the bed nucleus of the stria terminalis measured in the mouse brain slice Synapse 44 188 197
37. Moll GH. Mehnert C. Wicker M. Bock N. Rothenberger A. Ruther E. Huether G. 2000 Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood Brain ResDevBrain Res 119 251 257
38. Moron JA. Brockington A. Wise RA. Rocha BA. Hope BT. 2002 Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines JNeurosci 22 389 395
39. Nirenberg MJ. Chan J. Pohorille A. Vaughan RA. Uhl GR. Kuhar MJ. Pickel VM. 1997) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens JNeurosci 17 6899 6907
40. de Olmos JS. Heimer L. 1999 The concept of the ventral striatopallidal system and extended amygdala, in Advancing from the Ventral Striatum to the Extended Amygdala McGinty FJ., ed.), Vol. 877, pp. 1 32 Ann. NY Acad. Sci. New York
41. Paxinos G. Watson C. 1988 The Rat Brain in Stereotaxic Coordinates 4th edn Academic Press
42. Phelix CF. Lipositis Z. Paull WK. 1992 Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation Brain ResBull 33 189 119
43. Pontieri FE. Tanda G. Di Chiara G. 1995 Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens ProcNatl AcadSciUSA 92 12304 12308
44. Pontieri FE. Tanda G. Orzi F. Di Chiara G. 1996 Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs Nature 382 255 257
45. Pudovkina OL. Kawahara Y. de Vries J. Westerink BH. 2001 The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis Brain Res 906 38 45
46. Raiteri M. Del Carmine R. Bertolini A. Levi G. 1977 Effects of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine EurJPharmacol 41 133 143
47. Ritz MC. Lamb RJ. Goldberg SR. Kuhar MJ. 1987 Cocaine receptors on dopamine transporter are related to self-administration of cocaine Science 237 1219 1223
48. Rocha BA. Fumagalli F. Gainetdinov RR. Jones SR. Ator R. Giros B. Miller GW. Caron MG. 1998 Cocaine self-administration in dopamine-transporter knockout mice NatNeurosci 1 132 137
49. Seamans JK. Yang CR. 2004 The principal features and mechanisms of dopamine modulation in the prefrontal cortex ProgNeurobiol 74 1 58
50. Sesack SR. Hawrylak VA. Matus C. Guido MA. Levey AI. 2001 Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter JNeurosci 18 2697 2708
51. Sora I. Wichems C. Takahasci N. Li XF. Zeng Z. Revay R. Lesch KL. Murphy DL. Uhl GR. 1998 Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice ProcNatl AcadSciUSA 9 7699 7704
52. Spencer T. Biederman J. Wilens T. Prince J. Hatch M. Jones J. Harding M. Faraone SV. Seidman L. 1998 Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder AmJPsychiatry 155 693 695
53. Sullivan RM. 2004 Hemispheric asymmetry in stress processing in rat prefrontal cortex and the role of mesocortical dopamine Stress 7 131 143
54. Sullivan RM. Brake WG. 2003 What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function BehavBrain Res 146 43 55
55. Sulzer D. Rayport S. 1990 Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action Neuron 5 797 808
56. Sulzer D. Chen TK. Lau YY. Kristensen H. Rayport S. Ewing A. 1995 Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport JNeurosci 15 4102 4108
57. Tanda G. Carboni E. Frau R. Di Chiara G. 1994 Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) 115 285 288
58. Tanda G. Pontieri FE. Frau R. Di Chiara G. 1997 Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine EurJNeurosci 9 2077 2085
59. Valentini V. Frau R. Di Chiara G. 2003 Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine JNeurochem 88 917 927
60. Wise RA. Bozarth MA. 1987 A psychomotor stimulant theory of addiction PsycholRev 94 469 492
61. Wong EHF. Sonders MS. Amara SG. et al. 2000 Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor BiolPsychiatry 47 818 829
62. Yamamoto BK. Novotney S. 1998 Regulation of extracellular dopamine by the norephrine transporter JNeurochem 71 274 280
63. Zham DS. Heimer L. 1993 Specificity in the efferent projection of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of the core and shell JCompNeurol 327 220 232